Retatrutide (GIP/GLP-1/Glucagon Triple Agonist)
A novel single-peptide triple agonist targeting GIP, GLP-1, and glucagon receptors. Extensively investigated for potent metabolic regulation, energy expenditure upregulation, and glycemic control.
Research Use Only: This product is intended solely for in vitro laboratory research and scientific study. Not for human or veterinary use.
Technical Reference
Product Data Sheet
Handle in a controlled laboratory environment with appropriate PPE.
Reconstitute only with sterile bacteriostatic water or acetic acid as appropriate.
Aliquot and store at −20 °C. Avoid repeated freeze-thaw cycles.
Not for human, veterinary, or agricultural use under any circumstances.
Dispose of in accordance with local laboratory waste regulations.
This product is an analytical reference material for in-vitro research only. It has not been evaluated by the FDA or any regulatory authority. Purchase and use must comply with all applicable laws in your jurisdiction.